• Cimzia Shows Promise in Managing nr-axSpA Disease Activity, Symptoms in Phase 3 Trial
  • Mylan and Fujifilm Kyowa Kirin to Commercialize Humira Biosimilar in EU
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • Secukinumab Treatment Linked to Inflammatory Bowel Disease Symptoms in Some Cases
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • Patient Support Services Linked with Better Health Outcomes in Ankylosing Spondylitis Patients
  • 4 More Canadian Provinces Add Erelzi to Public Drug Plans for Inflammatory Diseases
  • Ankylosing Spondylitis Patients More Likely to Develop COPD, Researchers Find
  • Pregnancy Can Affect Axial Spondyloarthritis Activity, Prospective Study Suggests
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • Increase in Early Spondyloarthritis Activity Linked to Decline in Physical Quality of Life, Study Shows
  • Spondylitis Association of America Launches National Campaign for Awareness Month